Form4insider filings, from the source

SEC Form 4 · accession 0001548241-15-000003

Yew Bio-Pharm Group, Inc. · YEWB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 6, 2015
Accepted (ET)
Mar 26, 2015 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001548240

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 6, 2015S5,000$0.35D208,300D
Common StockJan 6, 2015S2,500$0.30D205,800D
Common StockJan 6, 2015S10,000$0.27D195,800D
Common StockJan 8, 2015S2,700$0.27D193,100D
Common StockJan 8, 2015S9,000$0.23D184,100D
Common StockJan 8, 2015S5,500$0.22D178,600D
Common StockJan 8, 2015S5,000$0.25D173,600D
Common StockJan 8, 2015S6,000$0.30D167,600D
Common StockJan 8, 2015S6,000$0.30D161,600D
Common StockJan 8, 2015S6,500$0.30D155,100D
Common StockJan 8, 2015S4,000$0.31D151,100D
Common StockJan 8, 2015S1,000$0.31D150,100D
Common StockJan 8, 2015S5,000$0.29D145,100D
Common StockFeb 2, 2015S5,000$0.29D140,100D
Common StockFeb 3, 2015S1,440$0.30D138,660D
Common StockFeb 3, 2015S3,000$0.27D135,660D
Common StockFeb 3, 2015S2,500$0.26D133,160D
Common StockFeb 3, 2015S12$0.31D133,148D
Common StockFeb 3, 2015S17,000$0.25D116,148D
Common StockMar 2, 2015S2,500$0.25D113,648D
Common StockMar 3, 2015S7,488$0.29D106,160D
Common StockMar 4, 2015S2,500$0.31D103,660D
Common StockMar 5, 2015S20,000$0.31D83,660D
Common StockMar 6, 2015S83,660$0.25D0D

Table II — derivative securities

No Table II lines on this filing.